Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
William Brooks Gentry
Intervexion Therapeutics, Llc, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
InterveXion Therapeutics, LLC
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
The Investigator has an equity interest in InterveXion Therapeutics, LLC, a private company developing vaccines for treatment of human diseases, including drug abuse; and is involved in research that has the potential to affect the value of this company.
A Methamphetamine Conjugate Vaccine: From Manufacturing to IND
Our team has developed a new vaccine for treating the serious medical consequences of methamphetamine (METH) addiction that has the potential to reduce METH's devastating behavioral and societal effects. This innovative vaccine could provide an essential missing therapeutic component to reduce METH's rewarding effects and thereby prevent relapse to METH use for patients in addiction treatment programs. This project will manufacture the METH vaccine and perform all necessary testing in preparation for a first human clinical trial.
Filed on September 22, 2014.
Tell us what you know about William Brooks Gentry's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “William Brooks Gentry”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| William Brooks Gentry | Intervexion Therapeutics, Llc | Conflict of Interest | InterveXion Therapeutics, LLC | $0 - $4,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.